Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy

Athanassios Vozikis, David N. Cooper, Christina Mitropoulou, Manousos E. Kambouris, Angela Brand, Vita Dolzan, Paolo Fortina, Federico Innocenti, Ming Ta Michael Lee, Lada Leyens, Milan Macek, Fahd Al-Mulla, Barbara Prainsack, Alessio Squassina, Domenica Taruscio, Ron H. Van Schaik, Effy Vayena, Marc S. Williams, George P. Patrinos

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This paper aims to provide an overview of the rationale and basic principles guiding the governance of genomic testing services, to clarify their objectives, and allocate and define responsibilities among stakeholders in a health-care system, with a special focus on the EU countries. Particular attention is paid to issues pertaining to pricing and reimbursement policies, the availability of essential genomic tests which differs between various countries owing to differences in disease prevalence and public health relevance, the prescribing and use of genomic testing services according to existing or new guidelines, budgetary and fiscal control, the balance between price and access to innovative testing, monitoring and evaluation for cost-effectiveness and safety, and the development of research capacity. We conclude that addressing the specific items put forward in this article will help to create a robust policy in relation to pricing and reimbursement in genomic medicine. This will contribute to an effective and sustainable health-care system and will prove beneficial to the economy at large.

Original languageEnglish
Pages (from-to)352-363
Number of pages12
JournalPublic Health Genomics
Volume19
Issue number6
DOIs
Publication statusPublished - 01-01-2017

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy'. Together they form a unique fingerprint.

  • Cite this

    Vozikis, A., Cooper, D. N., Mitropoulou, C., Kambouris, M. E., Brand, A., Dolzan, V., Fortina, P., Innocenti, F., Lee, M. T. M., Leyens, L., Macek, M., Al-Mulla, F., Prainsack, B., Squassina, A., Taruscio, D., Van Schaik, R. H., Vayena, E., Williams, M. S., & Patrinos, G. P. (2017). Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy. Public Health Genomics, 19(6), 352-363. https://doi.org/10.1159/000449152